S&P 500
(0.11%) 5 024.06 points
Dow Jones
(0.19%) 37 976 points
Nasdaq
(0.29%) 15 651 points
Oil
(-0.08%) $78.94
Gas
(3.42%) $1.998
Gold
(-0.36%) $2 302.70
Silver
(-0.14%) $26.71
Platinum
(0.12%) $956.05
USD/EUR
(0.38%) $0.937
USD/NOK
(0.52%) $11.09
USD/GBP
(0.40%) $0.802
USD/RUB
(-1.20%) $92.14

Realaus laiko atnaujinimai Tandem Diabetes Care Inc [TNDM]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Devices
Upcoming Earnings Alert

Quarter results today
(amc 2024-05-02)

Expected move: +/- 6.61%

BUY
64.29%
return 43.22%
SELL
35.71%
return -3.72%
Atnaujinta2 geg. 2024 @ 17:18

-2.93% $ 35.14

PIRKIMAS 1118 min ago

@ $36.78

Išleistas: 1 geg. 2024 @ 22:39


Grąža: -4.46%


Ankstesnis signalas: geg. 1 - 22:01


Ankstesnis signalas: Pardavimas


Grąža: -1.20 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 17:18):

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally...

Stats
Šios dienos apimtis 358 578
Vidutinė apimtis 1.79M
Rinkos kapitalizacija 2.27B
EPS $0 ( 2024-05-01 )
Kita pelno data ( $0 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -10.24
ATR14 $2.42 (6.87%)
Insider Trading
Date Person Action Amount type
2024-03-15 Carpenter Rick Buy 405 Common Stock
2024-03-15 Carpenter Rick Sell 145 Common Stock
2024-03-15 Carpenter Rick Sell 405 Restricted Stock Unit
2024-02-27 Morrison Susan Buy 407 Common Stock
2024-02-27 Morrison Susan Sell 113 Common Stock
INSIDER POWER
62.95
Last 100 transactions
Buy: 113 075 | Sell: 24 727

Tūris Koreliacija

Ilgas: 0.76 (moderate)
Trumpas: 0.97 (very strong)
Signal:(51) Expect same movement, but be aware

Tandem Diabetes Care Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
GAINL0.983
TDAC0.927
ISNS0.883
APOP0.88
RMRM0.851
SQBG0.844
YMAB0.842
NTEC0.82
BROG0.819
HBNC0.807
10 Labiausiai neigiamai susiję koreliacijos
BOCH-0.954
SHSP-0.945
QADA-0.857
LMRK-0.851
MMAC-0.823

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Tandem Diabetes Care Inc Koreliacija - Valiuta/Žaliavos

The country flag -0.18
( neutral )
The country flag -0.39
( neutral )
The country flag -0.79
( moderate negative )
The country flag -0.73
( moderate negative )
The country flag 0.35
( neutral )
The country flag 0.32
( neutral )

Tandem Diabetes Care Inc Finansinės ataskaitos

Annual 2023
Pajamos: $747.72M
Bruto pelnas: $367.69M (49.17 %)
EPS: $-3.43
FY 2023
Pajamos: $747.72M
Bruto pelnas: $367.69M (49.17 %)
EPS: $-3.43
FY 2022
Pajamos: $801.22M
Bruto pelnas: $412.99M (51.54 %)
EPS: $-1.470
FY 2021
Pajamos: $702.80M
Bruto pelnas: $376.22M (53.53 %)
EPS: $0.260

Financial Reports:

No articles found.

Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.